Chenguang Biotech Group Co (SZSE:300138) Change In Payables And Accrued Expense : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Chenguang Biotech Group Co Change In Payables And Accrued Expense?

Chenguang Biotech Group Co's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Chenguang Biotech Group Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Mar. 2024 .

Chenguang Biotech Group Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was ¥0 Mil. It means Chenguang Biotech Group Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Chenguang Biotech Group Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Chenguang Biotech Group Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chenguang Biotech Group Co Change In Payables And Accrued Expense Chart

Chenguang Biotech Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Chenguang Biotech Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Chenguang Biotech Group Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Chenguang Biotech Group Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Chenguang Biotech Group Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Chenguang Biotech Group Co (SZSE:300138) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Chenguang Biotech Group Co Ltd (SZSE:300138) » Definitions » Change In Payables And Accrued Expense

Traded in Other Exchanges

N/A

Address

Number 1 Chenguang Road, Hebei Province, Quzhou, CHN, 057250

Website

http://www.cn-cg.com

Chenguang Biotech Group Co Ltd is engaged in the processing of agricultural products and herb extracts in China. Its products include natural colors, including paprika oleoresin, marigold oleoresin, curcumin, red rice red, red cabbage, and red beet; and natural spice extracts and essential oils, such as capsicum oleoresin, zanthoxylum oil and oleoresin, black pepper oil and oleoresin, ginger oil and oleoresin, turmeric oil, star anise oil and oleoresin, cumin oil and oleoresin, garlic oil and oleoresin, and common fennel oil and oleoresin.

Executives

Li Feng Fei	Executives
Zhou Jing	Directors, Directors, and Executives
Li Yue Zhai	Director
Lian Yun He	Executives
Chen Yun Xia	Executives
Zhao Tao	Supervisors
Yuan Xin Ying	Supervisors
Liu Zhang Lin	Independent director
Lu Qing Guo	Directors, executives
Zhou Fang Sheng	Independent director
Wang Shu Hong	Independent director
Liu Ying Shan	Director
Han Wen Jie	Executives
Liu Dong Ming	Supervisors
Yang Wen Fang	Supervisors

Chenguang Biotech Group Co (SZSE:300138) Headlines

No Headlines